Skip to main content
Erschienen in: Updates in Surgery 5/2022

12.07.2022 | Original Article

Prognostic value of LODDS in medullary thyroid carcinoma based on competing risk model and propensity score matching analysis

verfasst von: Zhe Xu Cao, Xin Weng, Jiang Sheng Huang, Xia Long

Erschienen in: Updates in Surgery | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Abstract

Log odds of positive lymph nodes (LODDS) is an independent prognostic factor for patients with medullary thyroid carcinoma (MTC). However, the optimal cutoff value for LODDS needs to be further confirmed, and previous studies have ignored the prevalent competing events of non-cancer deaths among patients with MTC, thus possibly overestimating the risk of death from cancer. The information of patients with MTC who underwent total thyroidectomy was collected from SEER database. Restricted cubic splines (RCS) were used to determine the optimal cutoff for LODDS. Moreover, patients’ overall survival (OS) and disease-specific survival (DSS) were determined using Kaplan–Meier and Cox proportional-hazards model. The competing risk models (CRM) were used to reduce the effect of competing events, and propensity score matching was performed to balance the confounding factors between groups. The cutoff value of LODDS determined by RCS was − 1.004, and a total of 2314 patients with MTC were recruited. In the CRM after PSM, factors such as age over 55 years at diagnosis, being male, treatment with chemotherapy or radiotherapy, unknown tumor size, and LODDS > − 1.004 were significantly associated with poor prognosis of patients both in univariate and multivariate analyses, while the presence of multifocal tumor indicated better prognosis. Patients with MTC who were over 55 years old at diagnosis, were male, received chemotherapy or radiation, had an unclear initial tumor size, and had LODDS > − 1.004 had a worse prognosis than patients with multifocal tumor.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Mohammadi M, Hedayati M (2017) A brief review on the molecular basis of medullary thyroid carcinoma. Cell J 18(4):485–492 (Epub 2017/01/04)PubMed Mohammadi M, Hedayati M (2017) A brief review on the molecular basis of medullary thyroid carcinoma. Cell J 18(4):485–492 (Epub 2017/01/04)PubMed
2.
Zurück zum Zitat Adam MA, Thomas S, Roman SA, Hyslop T, Sosa JA (2017) Rethinking the current american joint committee on cancer tnm staging system for medullary thyroid cancer. JAMA Surg 152(9):869–876 (Epub 2017/06/22)PubMedPubMedCentralCrossRef Adam MA, Thomas S, Roman SA, Hyslop T, Sosa JA (2017) Rethinking the current american joint committee on cancer tnm staging system for medullary thyroid cancer. JAMA Surg 152(9):869–876 (Epub 2017/06/22)PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Kandil E, Gilson MM, Alabbas HH, Tufaro AP, Dackiw A, Tufano RP (2011) Survival implications of cervical lymphadenectomy in patients with medullary thyroid cancer. Ann Surg Oncol 18(4):1028–1034 (Epub 2010/11/04)PubMedCrossRef Kandil E, Gilson MM, Alabbas HH, Tufaro AP, Dackiw A, Tufano RP (2011) Survival implications of cervical lymphadenectomy in patients with medullary thyroid cancer. Ann Surg Oncol 18(4):1028–1034 (Epub 2010/11/04)PubMedCrossRef
4.
Zurück zum Zitat Okusa T, Nakane Y, Boku T, Takada H, Yamamura M, Hioki K et al (1990) Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. Surg Gynecol Obstet 170(6):488–494 (Epub 1990/06/01)PubMed Okusa T, Nakane Y, Boku T, Takada H, Yamamura M, Hioki K et al (1990) Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. Surg Gynecol Obstet 170(6):488–494 (Epub 1990/06/01)PubMed
5.
Zurück zum Zitat Wang J, Hassett JM, Dayton MT, Kulaylat MN (2008) The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer. J Gastrointest Surg 12(10):1790–1796 (Epub 2008/08/19)PubMedCrossRef Wang J, Hassett JM, Dayton MT, Kulaylat MN (2008) The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer. J Gastrointest Surg 12(10):1790–1796 (Epub 2008/08/19)PubMedCrossRef
6.
Zurück zum Zitat Meng K, Luo H, Chen H, Guo H, Xia W (2019) Prognostic value of numbers of metastatic lymph node in medullary thyroid carcinoma: a population-based study using the seer 18 database. Medicine (Baltimore) 98(1):e13884 (Epub 2019/01/05)CrossRef Meng K, Luo H, Chen H, Guo H, Xia W (2019) Prognostic value of numbers of metastatic lymph node in medullary thyroid carcinoma: a population-based study using the seer 18 database. Medicine (Baltimore) 98(1):e13884 (Epub 2019/01/05)CrossRef
7.
Zurück zum Zitat Tang J, Jiang S, Gao L, Xi X, Zhao R, Lai X et al (2021) Construction and validation of a nomogram based on the log odds of positive lymph nodes to predict the prognosis of medullary thyroid carcinoma after surgery. Ann Surg Oncol 28(8):4360–4370 (Epub 2021/01/21)PubMedCrossRef Tang J, Jiang S, Gao L, Xi X, Zhao R, Lai X et al (2021) Construction and validation of a nomogram based on the log odds of positive lymph nodes to predict the prognosis of medullary thyroid carcinoma after surgery. Ann Surg Oncol 28(8):4360–4370 (Epub 2021/01/21)PubMedCrossRef
9.
Zurück zum Zitat Schneider DF, Chen H (2013) New developments in the diagnosis and treatment of thyroid cancer. CA Cancer J Clin 63(6):374–394 (Epub 2013/06/26)PubMedCrossRef Schneider DF, Chen H (2013) New developments in the diagnosis and treatment of thyroid cancer. CA Cancer J Clin 63(6):374–394 (Epub 2013/06/26)PubMedCrossRef
10.
Zurück zum Zitat Momin S, Chute D, Burkey B, Scharpf J (2017) Prognostic variables affecting primary treatment outcome for medullary thyroid cancer. Endocr Pract 23(9):1053–1058 (Epub 2017/07/07)PubMedCrossRef Momin S, Chute D, Burkey B, Scharpf J (2017) Prognostic variables affecting primary treatment outcome for medullary thyroid cancer. Endocr Pract 23(9):1053–1058 (Epub 2017/07/07)PubMedCrossRef
11.
Zurück zum Zitat Lee CR, Lee S, Son H, Ban E, Kang SW, Lee J et al (2016) Medullary thyroid carcinoma: a 30 year experience at one institution in korea. Ann Surg Treat Res 91(6):278–287 (Epub 2016/12/03)PubMedPubMedCentralCrossRef Lee CR, Lee S, Son H, Ban E, Kang SW, Lee J et al (2016) Medullary thyroid carcinoma: a 30 year experience at one institution in korea. Ann Surg Treat Res 91(6):278–287 (Epub 2016/12/03)PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Spolverato G, Ejaz A, Kim Y, Squires MH, Poultsides G, Fields RC et al (2015) Prognostic performance of different lymph node staging systems after curative intent resection for gastric adenocarcinoma. Ann Surg 262(6):991–998 (Epub 2015/01/08)PubMedCrossRef Spolverato G, Ejaz A, Kim Y, Squires MH, Poultsides G, Fields RC et al (2015) Prognostic performance of different lymph node staging systems after curative intent resection for gastric adenocarcinoma. Ann Surg 262(6):991–998 (Epub 2015/01/08)PubMedCrossRef
13.
Zurück zum Zitat Kim Y, Spolverato G, Amini N, Margonis GA, Gupta R, Ejaz A et al (2015) Surgical management of intrahepatic cholangiocarcinoma: defining an optimal prognostic lymph node stratification schema. Ann Surg Oncol 22(8):2772–2778 (Epub 2015/02/11)PubMedCrossRef Kim Y, Spolverato G, Amini N, Margonis GA, Gupta R, Ejaz A et al (2015) Surgical management of intrahepatic cholangiocarcinoma: defining an optimal prognostic lymph node stratification schema. Ann Surg Oncol 22(8):2772–2778 (Epub 2015/02/11)PubMedCrossRef
14.
Zurück zum Zitat Kılıç M, Gündoğdu SB, Özden S, Saylam B, Tez M (2018) The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma. Acta Chir Belg 118(1):1–6 (Epub 2017/07/04)PubMedCrossRef Kılıç M, Gündoğdu SB, Özden S, Saylam B, Tez M (2018) The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma. Acta Chir Belg 118(1):1–6 (Epub 2017/07/04)PubMedCrossRef
15.
Zurück zum Zitat Agnes A, Biondi A, Cananzi FM, Rausei S, Reddavid R, Laterza V et al (2019) Ratio-based staging systems are better than the 7th and 8th editions of the tnm in stratifying the prognosis of gastric cancer patients: a multicenter retrospective study. J Surg Oncol 119(7):948–957 (Epub 2019/02/12)PubMedCrossRef Agnes A, Biondi A, Cananzi FM, Rausei S, Reddavid R, Laterza V et al (2019) Ratio-based staging systems are better than the 7th and 8th editions of the tnm in stratifying the prognosis of gastric cancer patients: a multicenter retrospective study. J Surg Oncol 119(7):948–957 (Epub 2019/02/12)PubMedCrossRef
16.
Zurück zum Zitat Pei JP, Zhang CD, Fan YC, Dai DQ (2018) Comparison of different lymph node staging systems in patients with resectable colorectal cancer. Front Oncol 8:671 (Epub 2019/01/31)PubMedCrossRef Pei JP, Zhang CD, Fan YC, Dai DQ (2018) Comparison of different lymph node staging systems in patients with resectable colorectal cancer. Front Oncol 8:671 (Epub 2019/01/31)PubMedCrossRef
17.
Zurück zum Zitat Song YX, Gao P, Wang ZN, Tong LL, Xu YY, Sun Z et al (2011) Which is the most suitable classification for colorectal cancer, log odds, the number or the ratio of positive lymph nodes? PLoS ONE 6(12):e28937 (Epub 2011/12/17)PubMedPubMedCentralCrossRef Song YX, Gao P, Wang ZN, Tong LL, Xu YY, Sun Z et al (2011) Which is the most suitable classification for colorectal cancer, log odds, the number or the ratio of positive lymph nodes? PLoS ONE 6(12):e28937 (Epub 2011/12/17)PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS et al (2005) Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23(34):8706–8712 (Epub 2005/11/30)PubMedCrossRef Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS et al (2005) Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23(34):8706–8712 (Epub 2005/11/30)PubMedCrossRef
19.
Zurück zum Zitat Rosenberg R, Engel J, Bruns C, Heitland W, Hermes N, Jauch KW et al (2010) The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients. Ann Surg 251(6):1070–1078 (Epub 2010/05/21)PubMedCrossRef Rosenberg R, Engel J, Bruns C, Heitland W, Hermes N, Jauch KW et al (2010) The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients. Ann Surg 251(6):1070–1078 (Epub 2010/05/21)PubMedCrossRef
24.
Zurück zum Zitat Torresan F, Cavedon E, Mian C, Iacobone M (2018) Long-term outcome after surgery for medullary thyroid carcinoma: a single-center experience. World J Surg 42(2):367–375 (Epub 2017/11/15)PubMedCrossRef Torresan F, Cavedon E, Mian C, Iacobone M (2018) Long-term outcome after surgery for medullary thyroid carcinoma: a single-center experience. World J Surg 42(2):367–375 (Epub 2017/11/15)PubMedCrossRef
25.
Zurück zum Zitat Simões-Pereira J, Bugalho MJ, Limbert E, Leite V (2016) Retrospective analysis of 140 cases of medullary thyroid carcinoma followed-up in a single institution. Oncol Lett 11(6):3870–3874 (Epub 2016/06/18)PubMedPubMedCentralCrossRef Simões-Pereira J, Bugalho MJ, Limbert E, Leite V (2016) Retrospective analysis of 140 cases of medullary thyroid carcinoma followed-up in a single institution. Oncol Lett 11(6):3870–3874 (Epub 2016/06/18)PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Qu N, Shi RL, Luo TX, Wang YL, Li DS, Wang Y et al (2016) Prognostic significance and optimal cutoff of age in medullary thyroid cancer. Oncotarget 7(13):15937–15947 (Epub 2016/02/26)PubMedPubMedCentralCrossRef Qu N, Shi RL, Luo TX, Wang YL, Li DS, Wang Y et al (2016) Prognostic significance and optimal cutoff of age in medullary thyroid cancer. Oncotarget 7(13):15937–15947 (Epub 2016/02/26)PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Kwon H, Kim WG, Jeon MJ, Song DE, Lee YM, Sung TY et al (2016) Dynamic risk stratification for medullary thyroid cancer according to the response to initial therapy. Endocrine 53(1):174–181 (Epub 2016/01/13)PubMedCrossRef Kwon H, Kim WG, Jeon MJ, Song DE, Lee YM, Sung TY et al (2016) Dynamic risk stratification for medullary thyroid cancer according to the response to initial therapy. Endocrine 53(1):174–181 (Epub 2016/01/13)PubMedCrossRef
28.
Zurück zum Zitat Verbeek HH, Meijer JA, Zandee WT, Kramp KH, Sluiter WJ, Smit JW et al (2015) Fewer cancer reoperations for medullary thyroid cancer after initial surgery according to ata guidelines. Ann Surg Oncol 22(4):1207–1213 (Epub 2014/10/16)PubMedCrossRef Verbeek HH, Meijer JA, Zandee WT, Kramp KH, Sluiter WJ, Smit JW et al (2015) Fewer cancer reoperations for medullary thyroid cancer after initial surgery according to ata guidelines. Ann Surg Oncol 22(4):1207–1213 (Epub 2014/10/16)PubMedCrossRef
29.
Zurück zum Zitat Matias-Guiu X, De Lellis R (2014) Medullary thyroid carcinoma: a 25-year perspective. Endocr Pathol 25(1):21–29 (Epub 2013/12/18)PubMedCrossRef Matias-Guiu X, De Lellis R (2014) Medullary thyroid carcinoma: a 25-year perspective. Endocr Pathol 25(1):21–29 (Epub 2013/12/18)PubMedCrossRef
30.
Zurück zum Zitat Choi JB, Lee SG, Kim MJ, Kim TH, Ban EJ, Lee CR et al (2018) Dynamic risk stratification in medullary thyroid carcinoma: single institution experiences. Medicine (Baltimore) 97(3):e9686 (Epub 2018/03/06)CrossRef Choi JB, Lee SG, Kim MJ, Kim TH, Ban EJ, Lee CR et al (2018) Dynamic risk stratification in medullary thyroid carcinoma: single institution experiences. Medicine (Baltimore) 97(3):e9686 (Epub 2018/03/06)CrossRef
31.
Zurück zum Zitat Siironen P, Hagström J, Mäenpää HO, Louhimo J, Arola J, Haglund C (2016) Lymph node metastases and elevated postoperative calcitonin: predictors of poor survival in medullary thyroid carcinoma. Acta Oncol 55(3):357–364 (Epub 2015/09/05)PubMedCrossRef Siironen P, Hagström J, Mäenpää HO, Louhimo J, Arola J, Haglund C (2016) Lymph node metastases and elevated postoperative calcitonin: predictors of poor survival in medullary thyroid carcinoma. Acta Oncol 55(3):357–364 (Epub 2015/09/05)PubMedCrossRef
32.
Zurück zum Zitat Roche AM, Fedewa SA, Chen AY (2016) Association of socioeconomic status and race/ethnicity with treatment and survival in patients with medullary thyroid cancer. JAMA Otolaryngol Head Neck Surg 142(8):763–771 (Epub 2016/06/03)PubMedCrossRef Roche AM, Fedewa SA, Chen AY (2016) Association of socioeconomic status and race/ethnicity with treatment and survival in patients with medullary thyroid cancer. JAMA Otolaryngol Head Neck Surg 142(8):763–771 (Epub 2016/06/03)PubMedCrossRef
33.
Zurück zum Zitat Kebebew E, Greenspan FS, Clark OH, Woeber KA, Grunwell J (2005) Extent of disease and practice patterns for medullary thyroid cancer. J Am Coll Surg 200(6):890–896 (Epub 2005/06/01)PubMedCrossRef Kebebew E, Greenspan FS, Clark OH, Woeber KA, Grunwell J (2005) Extent of disease and practice patterns for medullary thyroid cancer. J Am Coll Surg 200(6):890–896 (Epub 2005/06/01)PubMedCrossRef
34.
Zurück zum Zitat Randle RW, Balentine CJ, Leverson GE, Havlena JA, Sippel RS, Schneider DF et al (2017) Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years. Surgery 161(1):137–146 (Epub 2016/11/16)PubMedCrossRef Randle RW, Balentine CJ, Leverson GE, Havlena JA, Sippel RS, Schneider DF et al (2017) Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years. Surgery 161(1):137–146 (Epub 2016/11/16)PubMedCrossRef
35.
Zurück zum Zitat Ai L, Li N, Tan H-L, Wei B, Zhao Y-X, Chen P et al (2021) Effects of marital status on survival of medullary thyroid cancer stratified by age. Cancer Med 10(24):8829–8837 (Epub 2021/11/01)PubMedPubMedCentralCrossRef Ai L, Li N, Tan H-L, Wei B, Zhao Y-X, Chen P et al (2021) Effects of marital status on survival of medullary thyroid cancer stratified by age. Cancer Med 10(24):8829–8837 (Epub 2021/11/01)PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Fan W, Xiao C, Wu F (2018) Analysis of risk factors for cervical lymph node metastases in patients with sporadic medullary thyroid carcinoma. J Int Med Res 46(5):1982–1989 (Epub 2018/03/24)PubMedPubMedCentralCrossRef Fan W, Xiao C, Wu F (2018) Analysis of risk factors for cervical lymph node metastases in patients with sporadic medullary thyroid carcinoma. J Int Med Res 46(5):1982–1989 (Epub 2018/03/24)PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Nguyen XV, Roy Choudhury K, Tessler FN, Hoang JK (2018) Effect of tumor size on risk of metastatic disease and survival for thyroid cancer: implications for biopsy guidelines. Thyroid 28(3):295–300 (Epub 2018/01/28)PubMedCrossRef Nguyen XV, Roy Choudhury K, Tessler FN, Hoang JK (2018) Effect of tumor size on risk of metastatic disease and survival for thyroid cancer: implications for biopsy guidelines. Thyroid 28(3):295–300 (Epub 2018/01/28)PubMedCrossRef
39.
Zurück zum Zitat Sullivan MW, Camacho FT, Mills AM, Modesitt SC (2019) Missing information in statewide and national cancer databases: correlation with health risk factors, geographic disparities, and outcomes. Gynecol Oncol 152(1):119–126 (Epub 2018/11/01)PubMedCrossRef Sullivan MW, Camacho FT, Mills AM, Modesitt SC (2019) Missing information in statewide and national cancer databases: correlation with health risk factors, geographic disparities, and outcomes. Gynecol Oncol 152(1):119–126 (Epub 2018/11/01)PubMedCrossRef
40.
Zurück zum Zitat Erickson LA, Vrana JA, Theis J, Rivera M, Lloyd RV, McPhail E et al (2015) Analysis of amyloid in medullary thyroid carcinoma by mass spectrometry-based proteomic analysis. Endocr Pathol 26(4):291–295 (Epub 2015/08/26)PubMedCrossRef Erickson LA, Vrana JA, Theis J, Rivera M, Lloyd RV, McPhail E et al (2015) Analysis of amyloid in medullary thyroid carcinoma by mass spectrometry-based proteomic analysis. Endocr Pathol 26(4):291–295 (Epub 2015/08/26)PubMedCrossRef
41.
Zurück zum Zitat Essig GF Jr, Porter K, Schneider D, Arpaia D, Lindsey SC, Busonero G et al (2016) Multifocality in sporadic medullary thyroid carcinoma: an international multicenter study. Thyroid 26(11):1563–1572 (Epub 2016/11/02)PubMedPubMedCentralCrossRef Essig GF Jr, Porter K, Schneider D, Arpaia D, Lindsey SC, Busonero G et al (2016) Multifocality in sporadic medullary thyroid carcinoma: an international multicenter study. Thyroid 26(11):1563–1572 (Epub 2016/11/02)PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Machens A, Hauptmann S, Dralle H (2007) Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer. World J Surg 31(10):1960–1965 (Epub 2007/08/01)PubMedCrossRef Machens A, Hauptmann S, Dralle H (2007) Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer. World J Surg 31(10):1960–1965 (Epub 2007/08/01)PubMedCrossRef
43.
Zurück zum Zitat Kaliszewski K, Zubkiewicz-Kucharska A, Wojtczak B, Strutyńska-Karpińska M (2016) Multi- and unifocal thyroid microcarcinoma: are there any differences? Adv Clin Expe Med : Off Organ Wroclaw Medl Univ 25(3):485–492 (Epub 2016/09/16)CrossRef Kaliszewski K, Zubkiewicz-Kucharska A, Wojtczak B, Strutyńska-Karpińska M (2016) Multi- and unifocal thyroid microcarcinoma: are there any differences? Adv Clin Expe Med : Off Organ Wroclaw Medl Univ 25(3):485–492 (Epub 2016/09/16)CrossRef
Metadaten
Titel
Prognostic value of LODDS in medullary thyroid carcinoma based on competing risk model and propensity score matching analysis
verfasst von
Zhe Xu Cao
Xin Weng
Jiang Sheng Huang
Xia Long
Publikationsdatum
12.07.2022
Verlag
Springer International Publishing
Erschienen in
Updates in Surgery / Ausgabe 5/2022
Print ISSN: 2038-131X
Elektronische ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-022-01320-7

Weitere Artikel der Ausgabe 5/2022

Updates in Surgery 5/2022 Zur Ausgabe

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.